Bone Marrow Aspiration Concentrate and Platelet Rich Plasma for Osteochondral Repair in a Porcine Osteochondral Defect Model

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Aug 17

PMID 23951201

Citations 30

Authors

Marcel Betsch

Johannes Schneppendahl

Simon Thuns

Monika Herten

Martin Sager

Pascal Jungbluth

Mohssen Hakimi

Michael Wild

Affiliations

Soon will be listed here.

Abstract

Background: Bone marrow aspiration concentrate (BMAC) may possess a high potency for cartilage and osseous defect healing because it contains stem cells and multiple growth factors. Alternatively, platelet rich plasma (PRP), which contains a cocktail of multiple growth factors released from enriched activated thrombocytes may potentially stimulate the mesenchymal stem cells (MSCs) in bone marrow to proliferate and differentiate.

Methods: A critical size osteochondral defect (10×6 mm) in both medial femoral condyles was created in 14 Goettinger mini-pigs. All animals were randomized into the following four groups: biphasic scaffold alone (TRUFIT BGS, Smith & Nephew, USA), scaffold with PRP, scaffold with BMAC and scaffold in combination with BMAC and PRP. After 26 weeks all animals were euthanized and histological slides were cut, stained and evaluated using a histological score and immunohistochemistry.

Results: The thrombocyte number was significantly increased (p = 0.049) in PRP compared to whole blood. In addition the concentration of the measured growth factors in PRP such as BMP-2, BMP-7, VEGF, TGF-β1 and PDGF were significantly increased when compared to whole blood (p<0.05). In the defects of the therapy groups areas of chondrogenic tissue were present, which stained blue with toluidine blue and positively for collagen type II. Adding BMAC or PRP in a biphasic scaffold led to a significant improvement of the histological score compared to the control group, but the combination of BMAC and PRP did not further enhance the histological score.

Conclusions: The clinical application of BMAC or PRP in osteochondral defect healing is attractive because of their autologous origin and cost-effectiveness. Adding either PRP or BMAC to a biphasic scaffold led to a significantly better healing of osteochondral defects compared with the control group. However, the combination of both therapies did not further enhance healing.

Citing Articles

Establishing metrics of clinically meaningful change for treating knee osteoarthritis with a combination of autologous orthobiologics.

Centeno C, Ghattas J, Dodson E, Steinmetz N, Murphy M, Berger D Sci Rep. 2025; 15(1):7244.

PMID: 40021765 PMC: 11871318. DOI: 10.1038/s41598-025-91972-3.

In Vitro Assessment of Injectable Bone Marrow Aspirate Concentrates Compared to Injectable Platelet-Rich Fibrin.

Fujioka-Kobayashi M, Koyanagi M, Inada R, Miyasaka A, Satomi T Tissue Eng Regen Med. 2024; 21(8):1233-1243.

PMID: 39495461 PMC: 11589058. DOI: 10.1007/s13770-024-00677-7.

Enhancement of Scaffold In Vivo Biodegradability for Bone Regeneration Using P28 Peptide Formulations.

Azaman F, Brennan Fournet M, Ab Hamid S, Zawawi M, da Silva Junior V, Devine D Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375823 PMC: 10304976. DOI: 10.3390/ph16060876.

Effect of Platelet-Rich Plasma on Autologous Chondrocyte Implantation for Chondral Defects: Results Using an In Vivo Rabbit Model.

Kato Y, Yanada S, Morikawa H, Okada T, Watanabe M, Takeuchi S Orthop J Sports Med. 2022; 10(3):23259671221079349.

PMID: 35295553 PMC: 8918747. DOI: 10.1177/23259671221079349.

Synergistic impact of platelet rich plasma-heparin sulfate with hydroxyapatite/zirconia on the osteoblast differentiation potential of adipose-derived mesenchymal stem cells.

Latifi M, Sani M, Salmannejad M, Kabir-Salmani M, Babakhanzadeh Bavanati H, Talaei-Khozani T Cell Tissue Bank. 2021; 23(4):669-683.

PMID: 34665403 DOI: 10.1007/s10561-021-09966-0.

References

Bekkers J, Bartels L, Vincken K, Dhert W, Creemers L, Saris D . Articular cartilage evaluation after TruFit plug implantation analyzed by delayed gadolinium-enhanced MRI of cartilage (dGEMRIC). Am J Sports Med. 2013; 41(6):1290-5. DOI: 10.1177/0363546513483536. View

Joshi N, Reverte-Vinaixa M, Diaz-Ferreiro E, Dominguez-Oronoz R . Synthetic resorbable scaffolds for the treatment of isolated patellofemoral cartilage defects in young patients: magnetic resonance imaging and clinical evaluation. Am J Sports Med. 2012; 40(6):1289-95. DOI: 10.1177/0363546512441585. View

Weibrich G, Kleis W, Hafner G, Hitzler W, Wagner W . Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res. 2003; 14(3):357-62. DOI: 10.1034/j.1600-0501.2003.00810.x. View

Kon E, Filardo G, Delcogliano M, Fini M, Salamanna F, Giavaresi G . Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord. 2010; 11:220. PMC: 2954989. DOI: 10.1186/1471-2474-11-220. View

Mishra A, Tummala P, King A, Lee B, Kraus M, Tse V . Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods. 2009; 15(3):431-5. PMC: 2819709. DOI: 10.1089/ten.tec.2008.0534. View

Eppley B, Woodell J, Higgins J . Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004; 114(6):1502-8. DOI: 10.1097/01.prs.0000138251.07040.51. View

Ham O, Song B, Lee S, Choi E, Cha M, Lee C . The role of microRNA-23b in the differentiation of MSC into chondrocyte by targeting protein kinase A signaling. Biomaterials. 2012; 33(18):4500-7. DOI: 10.1016/j.biomaterials.2012.03.025. View

Johnstone B, Hering T, Caplan A, Goldberg V, Yoo J . In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998; 238(1):265-72. DOI: 10.1006/excr.1997.3858. View

Rudert M . Histological evaluation of osteochondral defects: consideration of animal models with emphasis on the rabbit, experimental setup, follow-up and applied methods. Cells Tissues Organs. 2002; 171(4):229-40. DOI: 10.1159/000063125. View

10.

Schaefer D, Martin I, Jundt G, Seidel J, Heberer M, Grodzinsky A . Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum. 2002; 46(9):2524-34. DOI: 10.1002/art.10493. View

11.

Tanaka T, Komaki H, Chazono M, Fujii K . Use of a biphasic graft constructed with chondrocytes overlying a beta-tricalcium phosphate block in the treatment of rabbit osteochondral defects. Tissue Eng. 2005; 11(1-2):331-9. DOI: 10.1089/ten.2005.11.331. View

12.

Veronesi F, Giavaresi G, Tschon M, Borsari V, Aldini N, Fini M . Clinical use of bone marrow, bone marrow concentrate, and expanded bone marrow mesenchymal stem cells in cartilage disease. Stem Cells Dev. 2012; 22(2):181-92. DOI: 10.1089/scd.2012.0373. View

13.

Alsousou J, Thompson M, Hulley P, Noble A, Willett K . The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br. 2009; 91(8):987-96. DOI: 10.1302/0301-620X.91B8.22546. View

14.

Rudert M, Wilms U, Hoberg M, Wirth C . Cell-based treatment of osteochondral defects in the rabbit knee with natural and synthetic matrices: cellular seeding determines the outcome. Arch Orthop Trauma Surg. 2005; 125(9):598-608. DOI: 10.1007/s00402-005-0008-2. View

15.

Borzini P, Mazzucco L . Tissue regeneration and in loco administration of platelet derivatives: clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms. Transfusion. 2005; 45(11):1759-67. DOI: 10.1111/j.1537-2995.2005.00600.x. View

16.

Ahern B, Parvizi J, Boston R, Schaer T . Preclinical animal models in single site cartilage defect testing: a systematic review. Osteoarthritis Cartilage. 2008; 17(6):705-13. DOI: 10.1016/j.joca.2008.11.008. View

17.

Hermann P, Huber S, Herrler T, Von Hesler C, Andrassy J, Kevy S . Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activity. Cell Transplant. 2008; 16(10):1059-69. View

18.

Marx R . Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent. 2002; 10(4):225-8. DOI: 10.1097/00008505-200110000-00002. View

19.

Jager M, Herten M, Fochtmann U, Fischer J, Hernigou P, Zilkens C . Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res. 2010; 29(2):173-80. DOI: 10.1002/jor.21230. View

20.

Castillo T, Pouliot M, Kim H, Dragoo J . Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2010; 39(2):266-71. DOI: 10.1177/0363546510387517. View